We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGTZ
5051
Defiance Daily Target 2x Short RGTI ETF
RGTZ
$65.3M
$353 ﹤0.01%
19
-7
-27% -$363
EUFN icon
5052
iShares MSCI Europe Financials ETF
EUFN
$4.13B
$351 ﹤0.01%
9
+4
+80% +$151
CJMB
5053
Callan JMB Inc
CJMB
$14.7M
$349 ﹤0.01%
434
-1,636
-79% -$1.56K
FRA icon
5054
BlackRock Floating Rate Income Strategies Fund
FRA
$372M
$341 ﹤0.01%
+31
New +$342
AEC
5055
Anfield Energy
AEC
$72.6M
$341 ﹤0.01%
+78
New +$378
NMTC icon
5056
NeuroOne Medical Technologies
NMTC
$12.1M
$340 ﹤0.01%
+112
New +$457
AMZU icon
5057
Direxion Daily AMZN Bull 2X ETF
AMZU
$258M
$332 ﹤0.01%
10
-6,269
-100% -$240K
GXPT
5058
Global X PureCap MSCI Information Technology ETF
GXPT
$142M
$327 ﹤0.01%
+10
New +$307
NCL
5059
DELISTED
Northann Corp
NCL
$325 ﹤0.01%
2,047
-2
-0.1% –
PETS icon
5060
PetMed Express
PETS
$33.2M
$323 ﹤0.01%
+168
New +$357
ICCC icon
5061
ImmuCell
ICCC
$90.2M
$322 ﹤0.01%
+32
New +$283
BTAI
5062
DELISTED
BioXcel Therapeutics
BTAI
$320 ﹤0.01%
227
-1,491
-87% -$1.75K
ASTL icon
5063
Algoma Steel
ASTL
$450M
$316 ﹤0.01%
78
-3,777
-98% -$18.1K
ETHW
5064
Bitwise Ethereum ETF
ETHW
$286M
$316 ﹤0.01%
28
-15
-35% -$221
GHY
5065
PGIM Global High Yield Fund
GHY
$451M
$315 ﹤0.01%
26
+16
+160% +$190
BFRI icon
5066
Biofrontera
BFRI
$17.5M
$314 ﹤0.01%
+332
New +$328
NVS icon
5067
Novartis
NVS
$276B
$313 ﹤0.01%
+2
New +$300
RBLU
5068
T-REX 2X Long RBLX Daily Target ETF
RBLU
$12.1M
$312 ﹤0.01%
35
+6
+21% +$51
NDRA icon
5069
ENDRA Life Sciences
NDRA
$9.06M
$309 ﹤0.01%
+58
New +$295
RDWR icon
5070
Radware
RDWR
$1.24B
$309 ﹤0.01%
+10
New +$277
WYFL
5071
Defiance Daily Target 2X Long WYFI ETF
WYFL
$1.79M
$308 ﹤0.01%
+10
New +$246
BBAX icon
5072
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.58B
$299 ﹤0.01%
+5
New +$307
TNON icon
5073
Tenon Medical
TNON
$2.09M
$299 ﹤0.01%
26
– –
MGRX icon
5074
Mangoceuticals
MGRX
$10.1M
$298 ﹤0.01%
783
-2
-0.3% -$1
IYE icon
5075
iShares US Energy ETF
IYE
$1.68B
$283 ﹤0.01%
+5
New +$303

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.